Matinas BioPharma MTNB Q1 2025 Annual earnings
Reported April 15, 2025 · Before market open
EPS-$1.68Miss by $0.90
EPS estimate-$0.78
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$25.0K
EPS estimate-$1.50
Versus estimates
Revenue
Diluted EPS
Q1 2026-$0.30Beat by $1.02Q4 2025-$0.24Beat by $1.08Q3 2025-$0.40Q2 2025-$1.03
Q1 2025-$1.68Miss by $0.90
Q4 2024-$1.50Miss by $0.72Ask the moment Matinas BioPharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Matinas BioPharma report Q1 2025 earnings?
- Matinas BioPharma (MTNB) reported Q1 2025 earnings on April 15, 2025 before market open.
- What were Matinas BioPharma's Q1 2025 revenue and EPS?
- Matinas BioPharma reported eps of $-1.68 for Q1 2025.
- Did Matinas BioPharma beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.78 by $0.90.
- How did Matinas BioPharma's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 12.0% from $-1.50.
- Where can I find Matinas BioPharma's Q1 2025 SEC filings?
- You can read the 10-K periodic report (0001641172-25-004882) directly on SEC EDGAR. The filing index links above go to sec.gov.